134 related articles for article (PubMed ID: 11856251)
21. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
Martin SJ; Pendland SL; Chen C; Schreckenberger PC; Danziger LH
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):167-71. PubMed ID: 9401809
[TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA; Lehr KH; Ren J
J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
[TBL] [Abstract][Full Text] [Related]
23. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation.
Marco F; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417
[TBL] [Abstract][Full Text] [Related]
24. Use of the microbial growth curve in postantibiotic effect studies of Legionella pneumophila.
Smith RP; Baltch AL; Michelsen PB; Ritz WJ; Alteri R
Antimicrob Agents Chemother; 2003 Mar; 47(3):1081-7. PubMed ID: 12604545
[TBL] [Abstract][Full Text] [Related]
25. The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp.
Ridgway GL; Salman H; Robbins MJ; Dencer C; Felmingham D
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():31-4. PubMed ID: 9484871
[TBL] [Abstract][Full Text] [Related]
26. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.
Horwitz MA; Silverstein SC
J Clin Invest; 1983 Jan; 71(1):15-26. PubMed ID: 6848556
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
Moffie BG; Mouton RP
J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075
[TBL] [Abstract][Full Text] [Related]
29. The antibacterial activity of compounds isolated from oakmoss against Legionella pneumophila and other Legionella spp.
Nomura H; Isshiki Y; Sakuda K; Sakuma K; Kondo S
Biol Pharm Bull; 2012; 35(9):1560-7. PubMed ID: 22975509
[TBL] [Abstract][Full Text] [Related]
30. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
Onody C; Matsiota-Bernard P; Nauciel C
J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
[TBL] [Abstract][Full Text] [Related]
31. A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas.
Bébéar C; Bouanchaud DH
J Antimicrob Chemother; 1997 May; 39 Suppl A():59-62. PubMed ID: 9511064
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.
Baltch AL; Smith RP; Franke MA; Michelsen PB
Antimicrob Agents Chemother; 1998 Dec; 42(12):3153-6. PubMed ID: 9835507
[TBL] [Abstract][Full Text] [Related]
33. In-vitro activity of antibiotics against Legionella pneumophila isolates from water systems.
Tsakris A; Alexiou-Daniel S; Souliou E; Antoniadis A
J Antimicrob Chemother; 1999 Nov; 44(5):693-5. PubMed ID: 10552988
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.
Pasculle AW; Dowling JN; Weyant RS; Sniffen JM; Cordes LG; Gorman GM; Feeley JC
Antimicrob Agents Chemother; 1981 Dec; 20(6):793-9. PubMed ID: 7325645
[TBL] [Abstract][Full Text] [Related]
35. Assessment of antibiotic susceptibility of Legionella pneumophila isolated from water systems in Poland.
Sikora A; Gładysz I; Kozioł-Montewka M; Wójtowicz-Bobin M; Stańczak T; Matuszewska R; Krogulska B
Ann Agric Environ Med; 2017 Mar; 24(1):66-69. PubMed ID: 28378991
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility study of BMS-284756 against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 2001; 41(1-2):79-82. PubMed ID: 11687318
[TBL] [Abstract][Full Text] [Related]
37. Evaluations of the Etest for antimicrobial susceptibility testing of Legionella pneumophila, including validation of the imipenem and sparfloxacin strips.
Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 1994 Nov; 20(3):159-62. PubMed ID: 7874883
[TBL] [Abstract][Full Text] [Related]
38. Environmental surveillance and in vitro activity of antimicrobial agents against Legionella pneumophila isolated from hospital water systems in Campania, South Italy: a 5-year study.
Torre I; Alfano R; Borriello T; De Giglio O; Iervolino C; Montagna MT; Scamardo MS; Pennino F
Environ Res; 2018 Jul; 164():574-579. PubMed ID: 29625340
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
Gómez-Lus R; Adrián F; del Campo R; Gómez-Lus P; Sánchez S; García C; Rubio MC
Int J Antimicrob Agents; 2001 Jul; 18(1):49-54. PubMed ID: 11463526
[TBL] [Abstract][Full Text] [Related]
40. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs.
Saito A; Koga H; Shigeno H; Watanabe K; Mori K; Kohno S; Shigeno Y; Suzuyama Y; Yamaguchi K; Hirota M
J Antimicrob Chemother; 1986 Aug; 18(2):251-60. PubMed ID: 3759736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
